Pulmonary Embolism by Parker, Jill
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
Summer 2017 
Pulmonary Embolism 
Jill Parker 
jap_616@yahoo.com 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Nursing Commons 
Recommended Citation 
Parker, Jill, "Pulmonary Embolism" (2017). Nursing Student Class Projects (Formerly MSN). 269. 
https://digitalcommons.otterbein.edu/stu_msn/269 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Path of a PE 
PULMONARY EMBOLISM 
Jill Parker, BSN, RN 
Introduction Pathophysiological Processes References 
Coleman, D. M., Obi, A., & Henke, P. K. 
   (2015). Update in venous  
   thromboembolism pathophysiology, 
   diagnosis, and treatment for surgical 
   patients. Current Problems in Surgery,  
   52(6), 233-259.  
Deng, X., Li, Y., Zhou, L., Liu, C., Liu, M.,  
   Ding, N., & Shao, J. (2015). Gender  
   Differences in the Symptoms, Signs, 
   Disease History, Lesion Position and  
   Pathophysiology in Patients with  
   Pulmonary Embolism. PLOS ONE,  
   10(7), e0133993.  
Feng, L. B., Pines, J. M., Yusuf, H. R., &  
   Grosse, S. D. (2013). U.S. Trends in  
   Computed Tomography Use and  
   Diagnoses in Emergency Department 
   Visits by Patients With Symptoms  
   Suggestive of Pulmonary Embolism,  
   2001-2009. Academic Emergency  
   Medicine, 20(10), 1033-1040.  
Pulmonary embolism: Overview – Mayo 
   Clinic. (2016, August 8).  
Rali, P., Gandhi, V., & Malik, K. (2016).  
  Pulmonary Embolism. Critical Care  
  Nursing Quarterly, 39(2), 131-138.  
  doi:10.1097/CNQ.0000000000000106 
Shapiro, N., & Bhatt, S. (2016). Critical  
  Review and Update on the Treatment of 
   Acute and Chronic Pulmonary  
  Embolism.  Journal of Pharmacy  
  Practice, 29(1), 35-45.  
Sharifi, M., Vajo, Z., Freeman, W., Bay, C., 
  Sharifi, M., & Schwartz, F. (2015).  
  Transforming and Simplifying the 
  Treatment of Pulmonary Embolism:  
  “Safe Dose” Thrombolysis Plus New  
  Oral Anticoagulants. Lung, 193(3), 369- 
  374. doi:10.1007/s00408-015-9702-1 
Wilbur, J., & Shian, B. (2017). Deep  
  Venous Thrombosis and Pulmonary  
  Embolism: Current Therapy. American  
  Family Physician, 95(5), 295-302. 
Wood, K. E. (2002). Major pulmonary  
  embolism*: Review of a patho- 
  physiologic approach to the golden  
  hour of hemodynamically significant 
  pulmonary embolism. Chest, 121(3), 
  877-905. doi:10.1378/chest.121.3.8 
York, N. L., Kane, C. J., Smith, C., &  
  Minton, L. A. (2015). Care of the patient  
  with an acute pulmonary embolism. 
Dimensions Of Critical Care Nursing: 
DCCN, 34(1), 3-9. 
doi:10.1097/DCC.0000000000000082 
 
 
 
Figure 1. Pathophysiology of Cardiac Failure Caused by Pulmonary Embolism 
Underlying 
Pathophysiology 
     Patients with a pulmonary embolism 
often present with a set of nonspecific 
symptoms.  Therefore, it is important for 
the general population to understand 
symptoms that might indicate PE.  These 
include leg pain, swelling, or both, often 
in the calf, shortness of breath, chest 
pain, fever, excessive sweating, 
discolored or clammy skin, 
lightheadedness, and a rapid or irregular 
heartbeat ("Pulmonary embolism: 
Overview - Mayo Clinic," 2016).  
However, the actual diagnosis of PE 
requires careful clinical judgment.  At 
one end of the spectrum, patients may 
be completely asymptomatic, while at 
the other end they may present with 
cardiogenic shock.  Other symptoms that 
indicate more severe PE include 
hypotension, hypoxia, tachycardia, 
elevation of B-type natriuretic peptides 
or N-terminal pro-B-type natriuretic 
peptides or troponins, and EKG changes 
that suggest right ventricular strain 
(Shapiro & Bhatt, 2016, p. 36).   
 
     There are both acquired and genetic 
risk factors for PE.  Acquired factors 
include immobilization, the use of oral 
contraceptives or hormone replacement 
therapy, older age, a malignancy, trauma 
or fractures, pregnancy or having 
recently given birth, as well as obesity, 
and certain types of cardiac or 
neurologic disease, and a prior history 
or family history of DVT.  The use of 
central venous catheters or peripheral 
central catheter lines, immobilization, 
and postoperative infections are also 
conditions that carry a high risk of PE.  
    The diagnosis has implications to 
nursing care, as nurses must be able to 
educate patients about the causes and 
effects of the condition, the importance 
of treatment and follow up care, and 
emphasize steps to take to avoid another 
PE.  Nurses should assess and discuss 
each patient’s risk factors and ways to 
specifically lower chances of a 
recurrence of the condition.  In addition, 
they should ensure they patient 
recognizes any warning signs and new 
symptoms, and has a plan of action if 
symptoms do recur. 
     The topic of Pulmonary Embolism (PE) 
was selected because the author, Jill 
Parker BSN, RN, works in the Riverside 
Hospital Emergency Department (ED).  In 
the ED, diagnoses of Pulmonary 
Embolism are common, and are often not 
obvious when a patient arrives with chest 
pain or shortness of breath.  However, 
quick recognition and treatment of PEs 
are very important. 
 
     By creating this poster, the author 
hopes to provide a summary of current 
research that explains signs and 
symptoms of a Pulmonary Embolism, the 
underlying pathophysiology of the 
condition, and an explanation about why 
that is significant.  This important 
information, together with information 
about treatment and prevention, can 
serve as an accessible way to help 
educate patients about the condition.   
 
     As an Advanced Practice Nurse, the 
author plans to continue working with 
emergent patients, where fast and 
accurate diagnostic and treatment skills 
are crucial.  Patient education is an 
important resource in recognizing 
symptoms of PEs and knowing that they 
require immediate treatment.    
 
 
 
 
    
  Pulmonary embolism, together with 
deep venous thrombosis (DVT), are often 
together referred to as venous 
thromboembolism.  In the United States,  
the CDC estimates that: 
 
•   Approximately 900,000 people 
develop VTE each year 
 
•   Of that number, 60,000 to 100,000 die 
 
•   Ten to thirty percent of patients die 
within a month of diagnosis 
 
•   Sudden death is the first symptom in 
approximately 25% of that population 
 
Therefore,  it is extremely important to 
recognize the risk factors and symptoms 
of pulmonary embolism so that it can be 
avoided or treated immediately. 
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Implications for  
Nursing Care 
The diagnosis of pulmonary 
embolisms can be difficult, but the 
condition is common and can have very 
serious consequences.  Doctors and 
Advanced Practice Nurses must be aware 
of the underlying pathophysiology of the 
condition so they can effectively diagnose 
and treat it.  In addition, this knowledge 
helps to educate patients about risk 
factors, symptoms of the condition, the 
importance of treatment, and ways to 
prevent a recurrence.. 
Conclusion 
    Because of the very high incidence of 
morbidity and mortality in patients with 
a pulmonary embolism, as well as the 
difficulty in diagnosis, it is important 
that at-risk patients be screened for PE.  
The pathophysiology that leads to PE is 
significant, because of the consequences 
and risk associated with the diagnosis.  
PE Patients who have been treated have 
approximately an 8% mortality rate, and 
in untreated patients the mortality rate 
can be as high as 30% (Deng, 
Li, Zhou,  Liu, et al., 2015, p. 1).  
Therefore, detection and prevention of 
PE is critical. 
 
Significance of 
Pathophysiology 
A pulmonary embolism that travels to 
the heart causes cardiac failure due to 
increased wall stress and cardiac 
ischemia that makes up the Right 
Ventricle function and impairs the Left 
Ventricular output.  The embolism itself 
initiates the cycle shown below and to the 
left. 
The embolism travels to the heart and 
causes pressure on the right ventricle as 
well as an inadequate blood supply.  That 
leads to increased right ventricle volume, 
which results in a decreased left ventricle 
preload, which in turn causes decreased 
Cardiac Output (CO) and Mean Arterial 
Pressure (MAP).  This leads to decrease 
right ventricle Coronary Perfusion 
Pressure(CPP), which starts the cycle over 
again.  Wood, 2002, p. 881-882).   
Figure 2 – Illustration of  Pulmonary Embolism 
Figure 3 – Detailed View of Pulmonary 
Embolism 
 
Prevalence of PE 
Signs and Symptoms 
    The basic underlying cause of PEs is a 
blockage in one of the pulmonary 
arteries.  Usually, blood clots originate in 
the legs, break off, and travel to the 
lungs where they block blood flow.  A 
high level view of this process is 
illustrated in Figure 2 ("Pulmonary 
embolism: Overview - Mayo Clinic," 
2016). 
 
 Current 
scientific thinking suggests that the 
embolism event occurs at the wall of the 
vein.  This includes the inflammatory 
responses to, as well as the cause of the 
clot formation.  After a vascular injury, 
platelets form a hemostatic plug and 
start the aggregation process.  A platelet 
plug is formed, and then coagulation 
protein assembles and form a clot 
(Coleman, Obi & Henke, 2015, p. 4).  
If the blood clot breaks off and passes to 
the heart, it can cause cardiac failure.  
The underlying pathophysiological 
process of that cardiac failure is 
described in Figure 1 (Wood, 2002, 
p. 882). 
 
 
 Genetic risk factors include protein C or 
S deficiency, antothrombin deficiency, 
factor V Leiden and prothrombin 20210A 
gene variants, non-O blood groups 
(Coleman, Obi & Henke, 2015, p. 2-3).  
 
Figure 3 below provides a more 
detailed view of a PE.  A blood clot forms 
in the lung, travels through the 
bloodstream to the heart and through it, 
and then obstructs a blood vessel in the 
lung. 
